BackgroundCirculating microRNAs (miRNAs) are biomarkers for various diseases and physiological conditions in humans and mice; studies in domestic animals, particularly cattle, are limited. The importance of early pregnancy diagnosis (especially within the 21 day cow estrous cycle) in the livestock industry is extremely high. This study compared the circulating miRNAs in non-pregnant and pregnant Japanese Black cows, explored miRNAs as biomarkers for early pregnancy diagnosis, and established a measurement system that includes reference miRNA selection and the effect of hemolysis. MethodsmiRNA was extracted from the plasma of Japanese Black cows on day 21 after arti cial insemination and subjected to a customized bovine oligonucleotide microarray for expression analysis. Differentially expressed miRNAs and reference miRNA candidates were selected and validated by real-time quanti cation PCR (RT-qPCR). Their stability was evaluated using NormFinder software. Hemolyzed samples were prepared using plasma from ve cows in estrous cycle and subjected to RT-qPCR. ResultsA total of 124 miRNAs were detected in bovine plasma by microarray analysis in non-pregnant and pregnant cows. The levels of ve circulating miRNAs were signi cantly higher in pregnant cows than in non-pregnant cows, and 24 miRNAs were detected only in the pregnant group. NormFinder analysis and RT-qPCR validation showed that miR-2455 was an appropriate reference miRNA in the plasma of nonpregnant and pregnant Japanese Black cows and miR-19b, miR-25, miR-29a, and miR-148a were signi cantly higher in the pregnant group. These four circulating miRNAs did not change during the estrous cycle and were less affected by hemolysis. ConclusionsIn the current study, we found high levels of four miRNAs in the plasma of pregnant Japanese Black cows. Since these miRNAs are less affected by hemolysis, they may potentially be used as markers for early pregnancy diagnosis in cattle.
Background Circulating microRNAs (miRNAs) are biomarkers for various diseases and physiological conditions in humans and mice; studies in domestic animals, particularly cattle, are limited. The importance of early pregnancy diagnosis (especially within the 21 day cow estrous cycle) in the livestock industry is extremely high. This study compared the circulating miRNAs in non-pregnant and pregnant Japanese Black cows, explored miRNAs as biomarkers for early pregnancy diagnosis, and established a measurement system that includes reference miRNA selection and the effect of hemolysis. Methods miRNA was extracted from the plasma of Japanese Black cows on day 21 after artificial insemination and subjected to a customized bovine oligonucleotide microarray for expression analysis. Differentially expressed miRNAs and reference miRNA candidates were selected and validated by real-time quantification PCR (RT-qPCR). Their stability was evaluated using NormFinder software. Hemolyzed samples were prepared using plasma from five cows in estrous cycle and subjected to RT-qPCR. Results A total of 124 miRNAs were detected in bovine plasma by microarray analysis in non-pregnant and pregnant cows. The levels of five circulating miRNAs were significantly higher in pregnant cows than in non-pregnant cows, and 24 miRNAs were detected only in the pregnant group. NormFinder analysis and RT-qPCR validation showed that miR-2455 was an appropriate reference miRNA in the plasma of non-pregnant and pregnant Japanese Black cows and miR-19b, miR-25, miR-29a, and miR-148a were significantly higher in the pregnant group. These four circulating miRNAs did not change during the estrous cycle and were less affected by hemolysis. Conclusions In the current study, we found high levels of four miRNAs in the plasma of pregnant Japanese Black cows. Since these miRNAs are less affected by hemolysis, they may potentially be used as markers for early pregnancy diagnosis in cattle.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.